Ad is loading...
MRSJX
Price
$23.20
Change
-$0.20 (-0.85%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

MRSJX vs VTSNX

Header iconMRSJX vs VTSNX Comparison
Open Charts MRSJX vs VTSNXBanner chart's image
MFS Research International R4
Price$23.20
Change-$0.20 (-0.85%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
MRSJX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRSJX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSJX is a StrongBuy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. MRSJX (15.8B). VTSNX pays higher dividends than MRSJX: VTSNX (3.29) vs MRSJX (1.67). MRSJX was incepted earlier than VTSNX: MRSJX (20 years) vs VTSNX (14 years). MRSJX is a more actively managed with annual turnover of: 16.00 vs. VTSNX (4.00). MRSJX has a lower initial minimum investment than VTSNX: MRSJX (0) vs VTSNX (5000000). MRSJX (11.23) and VTSNX (10.92) have marching annual gain over last year. MRSJX return over 5 years is better than : 29.23 vs. VTSNX (15.91).
MRSJXVTSNXMRSJX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years14 years-
Gain YTD4.5524.535100%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets15.8B442B4%
Annual Yield % from dividends1.673.2951%
Returns for 1 year11.2310.92103%
Returns for 3 years-3.07-5.8652%
Returns for 5 years29.2315.91184%
Returns for 10 years62.4929.81210%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals